Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone
循环肿瘤细胞可预测接受达雷妥尤单抗、硼替佐米、来那度胺和地塞米松治疗的多发性骨髓瘤患者的预后
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2025030113
Bertamini, Luca; Fokkema, Cathelijne; Rodriguez-Otero, Paula; van Duin, Mark; Terpos, Evangelos; D'Agostino, Mattia; van der Velden, Vincent H J; van de Donk, Niels W C J; Delforge, Michel; Driessen, Christoph; Hajek, Roman; Einsele, Hermann; Vangsted, Annette; Vieyra, Diego; Attar, Ricardo; Sitthi-Amorn, Anna; Carson, Robin; Schjesvold, Fredrik; Robak, Pawel; Beksac, Meral; Spencer, Andrew; Broijl, Annemiek; Cupedo, Tom; Moreau, Philippe; Boccadoro, Mario; Sonneveld, Pieter